Home›People›Daniel Pelak
DP

Daniel Pelak

Director at Vertos Medical. Also a director at Alucent Biomedical.

DirectorPublic companyRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing Jun 6, 2023·Suggest an edit

About Daniel Pelak

Form D filings for Vertos Medical from 2009 to 2023 list Daniel Pelak as director.

Form D filings also name Daniel Pelak as a director at Alucent Biomedical.

Daniel Pelak reports to the SEC as a director of 3 public companies: K2M Group (KTWO), Spectranetics (SPNC) and AGA Medical (AGAM).

Daniel Pelak first appears on SEC filings in 2009.

Experience

This experience comes from SEC filings. The years are when the filings name Daniel Pelak in the role, so the role may have started earlier or lasted longer.

Vertos Medical Inc.
Director
2009 – 2023 · Aliso Viejo, CA
Alucent Biomedical, Inc.
Director
2020 – 2023 · Salt Lake City, UT
K2M Group Holdings, Inc.
Director
2014 – 2018 · Public company (KTWO)
Spectranetics Corp.
Director
2010 – 2017 · Public company (SPNC)
AGA Medical Holdings, Inc.
Director
2009 – 2010 · Public company (AGAM)

Key Colleagues at Startups

The people Daniel Pelak works with at each company, as listed on that company's latest Form D.

Vertos Medical Inc. · Form D, Jun 6, 2023
MB
Mike Boggs
Director
EW
Eric Wichems
Chief Executive Officer and director
Ittai Harel
Ittai Harel
Director
HH
Hugo Harrod
Director
ZS
RC
Rebecca Colbert
Executive officer
Alucent Biomedical, Inc. · Form D, Apr 20, 2023
JL
Julie Lautt
Director
JC
BK
Bruce Krattenmaker
Executive officer
KW
Kevin Warner
Executive officer
CJ
Colin Jackson
Executive officer
MG
Myles Greenberg
President and director
DF
David Flicek
Director
KK
Katalin Kauser
Executive officer
NP
Nick Pappas
Director
JI
James Isaacson
Executive officer
HH
Henry Hauser
Executive officer

Sources

  1. SECVertos Medical Inc. Form D, filed Jun 6, 2023
  2. SECAlucent Biomedical, Inc. Form D, filed Apr 20, 2023
  3. SECForms 3, 4 and 5 filed by Daniel Pelak (SEC filer 1197395)